Cannabis Law Report

JULY 29, 2021

When it comes to buying a cannabis enthusiast’s home, the resale value research is less clear, though 30% of realtors say they have struggled to sell a house where cannabis was grown. Legal cannabis raises home value. There’s been a lot of chatter surrounding cannabis and the real estate market.

Data 116

Data Legalization Education Programs 116

Veriheal

APRIL 23, 2024

Cannabis use is increasing all around the world. These surveys explore the motivations and methods behind cannabis usage for both medical purposes and recreational enjoyment. In this piece, we aim to delve into the use of cannabis among Generation Z (those born between 1997 and 2012) for purposes of happiness, healing, and relief.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

Veriheal

DECEMBER 14, 2021

In accordance with this, a new study found that states with legal cannabis markets have been less likely to experience incidences of EVALI, suggesting that properly regulated vape pens are not the problem. An Analysis of Nationwide EVALI Data. ” The study also discovered impacts from other variances in policies across states.

Data 98

Data Vaping Legalization Consumption 98

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s not really available in the cannabis industry,” he explained on the Cannabis Enigma podcast. Produced by Elana Goldberg and Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Veriheal

APRIL 11, 2024

Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. This data aligns with Americans’ rising acceptance of cannabis. The most popular qualifying conditions continue to be chronic pain and PTSD, some of which may be related to the pandemic.

Patients 109

Patients Chronic Pain Marijuana Conditions 109

Cannabis Law Report

MAY 1, 2022

A new report by New Frontier Data estimated that U.S. cannabis sales exceeded spirits (US$86 billion) last year, while matching spending on beer. legal and illicit cannabis consumer spending reached an estimated US$97 billion in 2021, according to a new report by New Frontier Data. With an estimated $97 billion in U.S.

Data 52

Data Legalization Consumption Collective 52

Cannabis Law Report

AUGUST 20, 2022

CHICAGO — Governor JB Pritzker and the Illinois Department of Financial and Professional Regulation (IDFPR) today issued three additional Conditional Adult Use Dispensing Organization Licenses to applicants selected in lotteries held in the summer of 2021. Secretary of the Illinois Department of Financial and Professional Regulation.

Conditions 52

Conditions Dispensary Programs Business 52

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. The development has been welcomed and comes as the nation’s doctors are said to be shifting their cultural stance from viewing ‘cannabis as a dirty word’.

Data 52

Data Patients Clinical Trials Business 52

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). The ORR is a web-based research platform open to adults and adult caregivers of dependents who are, or are considering, the use of cannabis or hemp products for therapeutic purposes.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.

CBD 295

CBD Clinical Trials Data Treatment 295

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data 52

Data Treatment Patients Chronic Pain 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Today, databases, predictive analytics, artificial intelligence , and machine learning are having widespread effects on cannabis businesses, investors, regulators, and consumers. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

SpeedWeed

AUGUST 18, 2021

adults who have tried cannabis is the highest it has ever been. As normalization continues to spread, 49% of Americans 18 years and older said they have tried cannabis—a 4% increase from 2019 and 2017—according to results from Gallup’s annual Consumption Habits poll conducted July 6-21. The percentage of U.S. Only 19% of U.S.

Conditions 52

Conditions Education Data Edibles 52

NORML

JUNE 19, 2020

The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.

Patients 347

Patients Chronic Pain Treatment Therapy 347

Leaf Science

DECEMBER 28, 2018

study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. The groundbreaking study conducted by New Frontier Data surveyed over 3,000 adult Americans to show people from all age groups and demographics in the U.S. A Fascinating insight into Cannabis user profiles can be found here.

Pharmaceutical 84

Pharmaceutical Data Recreational Topical 84

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 341

Chronic Pain Clinical Trials Data Patients 341

NORML

JUNE 18, 2019

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279

Patients Therapy Data Safety 279

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 193

Clinical Trials Chronic Pain Data Treatment 193

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Why Do MMJ Patients Use Cannabis? Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

NOVEMBER 14, 2019

Survey of more than 10,000 people by the Centre for Medicinal Cannabis shows might higher incidence than previously thought reports inews UK. million adults are now using “street cannabis ” to treat the symptoms of chronic conditions , according to the largest poll of its kind. They write. New guidelines.

Conditions 45

Conditions Data Medicine Collective 45

WeedAdvisor

JULY 21, 2019

The Financial Times also points out how Colombia’s advantages – cheap labour, better climate and plenty of experienced workers – help keep prices down and give the Colombian cannabis industry its competitive edge. Their ability to follow them will ultimately decide the Colombian cannabis industry’s fate. A Bombardment of Investors. .

Conditions 60

Conditions Seed-To-Sale Compliance Compliance 60

Veriheal

NOVEMBER 21, 2023

Veriheal remains dedicated to supporting the next generation of pioneers through its Innovation in Cannabis Scholarship. This year, we are proud to continue our investment in the next generation of cannabis industry leaders. Their one-of-a-kind innovations and solutions are invaluable to the future of cannabis.

Research and Development 108

Research and Development Consumption Education Data 108

Veriheal

AUGUST 24, 2023

Activities in cannabis farms are gradually picking up after the Washington D.C. authorities shut down cannabis facilities in April due to unacceptable levels of Dichlorodiphenyldichloroethylene (DDT)-related chemicals detected in cannabis harvest. There just isn’t experimental data available,” Simpson said.

Data 98

Data Safety Extraction Cannabis 98

Cannabis Law Report

NOVEMBER 19, 2019

CSE:GRIN | OTC: GRUSF) (“ Grown Rogue ” or the “ Company ”), a vertically-integrated, multi-state cannabis company, with operations and assets in Oregon, California, and Michigan, has released survey data suggesting the pricing in the Oregon cannabis market is recovering. . Survey Highlights. What Grown Rogue Sales Indicate.

Data 45

Data Dispensary Retail Recreational 45

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. But where do you begin when it comes to navigating the ever-evolving landscape of cannabis studies? Key Takeaways Stay updated with reliable sources to understand latest cannabis research.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 250

Clinical Trials Chronic Pain Cannabinoids Patients 250

Veriheal

DECEMBER 14, 2023

There is a persistent and common belief throughout society that using cannabis over an extended period of time (or, in some cases, even once) can lead to a decline in mental abilities and function. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

Chronic Pain 278

Chronic Pain Patients Therapy Data 278

Cannabis Law Report

AUGUST 23, 2021

The TGA recently released a new medical cannabis dashboard detailing a variety of information on both SAS-A and SAS-B approvals. They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

Veriheal

DECEMBER 6, 2021

Back in 2018, San Francisco voters approved a 1-5% cannabis business tax slated to go into effect early 2022. After three hard years for the city’s cannabis industry however, plans to implement the tax have gone out the window. Recent data from the California Legislative Analyst Office backs Mandelman’s claim.

Data 98

Data Retail Business Legislation 98

Veriheal

JULY 25, 2023

are increasingly relaxing their cannabis laws, it’s no surprise that the drug’s consumption has grown , especially among American workers. Also, the medical use of cannabis is legal in more than 36 states. But has this led to more positive cannabis drug tests? But has this led to more positive cannabis drug tests?

Safety 95

Safety Data Recreational Marijuana 95

NORML

NOVEMBER 1, 2019

Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access 176

Access Patients Chronic Pain Law 176

Cannabis Law Report

FEBRUARY 23, 2022

Kathy Hochul signed a bill today, clearing the way for qualified farmers to begin planting cannabis this spring. 8084-a , establishing conditional use cultivator licenses to cannabis cultivators who will then be able to process and distribute products. S8084A (ACTIVE) – SUMMARY. Michelle Hinchey’s bill S.8084-a

Legislation 105

Legislation Conditions Cultivation Agriculture 105

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar disorder.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98